Evidence map›Paper›PMID 42840874›Full record

ArticleColombia medica (Cali, Colombia)

Frailty in elderly chronic obstructive pulmonary disease patients: a cross-sectional study.

Mustafa Ilteris Bardakci, Fatih Ozcelik, Mihriban Cakir, Gulhan Ayhan Albayrak

Abstract read
In one paragraph

Article in Colombia medica (Cali, Colombia). The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Mustafa Ilteris BardakciUniversity of Health Sciences Hamidiye Etfal Training and Research Hospital Department of Chest Diseases Istanbul Turkey.ORCID https://orcid.org/0000-0002-9038-4049
Fatih OzcelikUniversity of Health Sciences Hamidiye Etfal Training and Research Hospital Department of Medical Biochemistry Istanbul Turkey.ORCID https://orcid.org/0000-0003-2439-3964
Mihriban CakirBirecik State Hospital Department of Medical Biochemistry Sanliurfa Turkey.ORCID https://orcid.org/0009-0000-5213-7234
Gulhan Ayhan AlbayrakUniversity of Health Sciences Hamidiye Etfal Training and Research Hospital Department of Chest Diseases Istanbul Turkey.ORCID https://orcid.org/0000-0003-1802-3844

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objective: This study aimed to determine frailty prevalence among patients aged ≥65 diagnosed with Chronic Obstructive Pulmonary Disease (COPD) and investigate its relationship with disease severity, hospitalization rates, and acute exacerbation frequency. Methods: This cross-sectional study evaluated 112 elderly patients with COPD. Patient records, pulmonary function tests, Modified Medical Research Council (mMRC) dyspnea scores, COPD Assessment Test (CAT) scores, and the previous year's exacerbations and hospitalizations were analyzed. Frailty was assessed using the FRAIL scale. Results: Frailty prevalence was 49.1% (55/112). A significant negative correlation was found between FRAIL and FEV1% values ( Conclusion: The FRAIL scale is strongly associated with higher rates of exacerbations and hospitalizations in elderly COPD patients, reflecting increased disease severity and poorer clinical outcomes.

Indexed as

Frail ElderlyFrailtyHospitalizationPulmonary Disease, Chronic ObstructiveAgedAged, 80 and overCross-Sectional StudiesDisease ProgressionDyspneaFemaleForced Expiratory VolumeHumansMalePrevalenceRespiratory Function TestsSeverity of Illness Indexchronic diseasedisease exacerbationfrail elderlyfrailtyhospitalizationphysiological phenomenapublic healthpulmonary disease, chronic obstructivepulmonary function tests

Identifiers

PMID42840874
PMCPMC13641682

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.